Infrared-spectroscopy: A non-invasive tool for medical diagnostics and drug analysis

Current Medicinal Chemistry

Volumn 17, Issue 26, 2010, Pages 2956-2966

  Hahn, H ^a   Pallua, J D ^a   Pezzei, C ^a   Huck Pezzei, V ^a   Bonn, G K ^a   Huck, C W ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Allergens; Alzheimer's disease; Drugs; Glucose monitoring; Infrared spectroscopy; Medicine; Pharmaceuticals

Indexed keywords

ALLERGEN;

ALZHEIMER DISEASE; ARTICLE; BLOOD GLUCOSE MONITORING; HUMAN; IN VIVO STUDY; INFRARED SPECTROSCOPY; INSULIN DEPENDENT DIABETES MELLITUS; SCALE UP;

ATHEROSCLEROSIS; CHEMISTRY, PHARMACEUTICAL; DIAGNOSIS, COMPUTER-ASSISTED; GLIOBLASTOMA; HUMANS; SPECTROPHOTOMETRY, INFRARED;

EID: 77955643480     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710792065063     Document Type: Article

References (91)

1. Vendeland, D.; Pakholkov, G.V.; Arzamastsev, A.P. Prospects for using IR spectroscopy in the pharmaceutical analysis of penicillin group preparations. II. IR spectroscopy as a method of identifying oxacillins and phenoxymethl penicillins. Farmatsevtychnyi zhurnal, 1975, 30(3), 33-38.
2. Vendeland, D.; Arzamastsev, A. P. Prospects for using IR spectros-copy in the pharmaceutical analysis of penicillin group preparations. I. IR spectroscopy as a method of identifying benzylpenicil-lins and ampicillins. Farmatsevtychnyi zhurnal, 1975, 1, 50-56.
3. Shoemaker, M.J.; Sideman, L. Letter: Use of infrared spectroscopy in drug analysis. Clin. Chem., 1976, 22(8), 1411.
4. Mynka, A.F.; Liuta, M.L. Use of IR spectroscopy for the quantitative determination of drug preparations containing the carbonyl group. Farmatsevtychnyi zhurnal, 1976, 4, 34-38.
5. Lunardelli, M.; De Marchi, G.; De Martiis, F. Application of near infrared reflectance spectroscopy (NIRS) to process control in the pharmaceutical industry. Bull. Chim. Farm., 1988, 127(1), 13-19.
6. Toffel-Nadolny, P.; Paulig, G. Proof of drugs of minute quantities using IR spectroscopy. Arch Krimino, 1980, 165(3-4), 111-119.
7. Gonzalez, F.; Pous, R. Quality control in manufacturing process by near infrared spectroscopy. J. Pharm. Biomed. 1995, 13(4-5), 419-423.
8. Amigo, J.M.; Ravn, C. Direct quantification and distribution assessment of major and minor components in pharmaceutical tablets by NIR-chemical imaging. Eur. J. Pharm. Sci. 2009, 37(2), 76-82.
9. Xiang, D.; Berry, J.; Buntz, S.; Gargiulo, P.; Cheney, J.; Joshi, Y.; Wabuyele, B.; Wu, H.; Hamed, M.; Hussain, A.S.; Khan, M.A. Robust calibration design in the pharmaceutical quantitative meas-urments with near-infrared (NIR) spectroscopy: avoiding the chemometric pitfalls. J. Pharm. Sci. 2009, 98(3), 1155-1166.
10. Sarraguca, M.C.; Lopes, J.A. Quality control of pharmaceuticals with NIR: from lab to process line. Vib. Spectrosc. 2009, 49(2), 204-210.
11. Wang, L.; Mizaikoff, B. Application of multivariate data-analysis techniques to biomedical diagnostics based on mid-infrared spectroscopy. Anal. Bioanal. Chem. 2008, 391, 1641-1654.
12. Petter, C. H.; Heigl, N.; Rainer, M.; Bakry, R.; Pallua, J.; Bonn, G. K.; Huck, C. W. Development and application of fourier-transform infrared chemical imaging of tumour in human tissue. Curr. Med. Chem. 2009,16(3), 318-326.
13. Kondepati, V.R.; Heise, H.M.; Backhaus, J. Recent applications of near-infrared spectroscopy in cancer diagnosis and therapy. Anal. Bioanal. Chem. 2008, 390, 125-139.
14. 2A agonist on the allergen-induced late asthmatic response. Allergy 2008, 63(1), 75-80.
15. Constantin, C.; Quirce, S.; Grote, M.; Touraev, A.; Swoboda, I.; Stoecklinger, A.; Mari, A.; Thalhamer, J.; Heberle-Bors, E.; Va-lenta, R. Molecular and immunological characterization of a wheat serine proteinase inhibitor as a novel allergen in baker's asthma. J. Immunol. 2008, 180(11), 7451-7460.
16. Tovey, E.R.; Almqvist, C.; Li, Q.; Crisafulli, D.; Marks, G.B. Nonlinear relationship of mite allergen exposure to mite sensitization and asthma in a birth cohort. J. Allergy Clin. Immunol. 2008, 122(1), 114-118.
17. Volozhin, A.I.; Babakhin, A.A.; Dubova, L.V.; Sorokin, D.A. Allergy to metals used in orthodontics and methods for its diagnosis. Stomatologiya 2004, 5, 57.
18. Forte, G.; Petrucci, F.; Bocca, B. Metal allergens of growing significance: epidemiology, immunotoxicology, strategies for testing and prevention. Inflamm. Allergy Drug Targets 2008, 7(3), 145-162.
19. Mayer, C.; Verheijen, R.; Stich, N.; Schalkhammer, T.G.M. Biomedical instrumentation based on micro- and nanotechnology. Proc. SPIE, 2001, 5265, 134.
20. Immer, U.; Schmitt, K.; Johnson, K.; Fellinger, A. Easy analysis of allergen residues in food: a new lateral flow test and an ELISA. ACS Symposium Series 2008, 1001, 476-481.
21. Lehrer, S.B.; Ayuso, R.; Reese, G. Seafood allergy and allergens: a review. Marine Biotechnol. 2002, 5(4), 339-348.
22. Gaudin, J.C.; Rabesona, H.; Choiset, Y.; Yeretssian, G.; Chobert, J.M.; Sakanyan, V.; Drouet, M.; Haertl'e, T. Assessment of the immunoglobulin E-mediated immune response to milk-specific proteins in allergic patients using microarrays. Clin. Exp. Allergy 2008, 38(4), 686-693.
23. Rigby, N.M.; Marsh, J.; Sancho, A.I.; Wellner, K.; Akkerdaas, J.; van Ree, R.; Knulst, A.; Fernández-Rivas, M.; Brettlova, V.; Schilte, P.P.; Summer, C.; Pumphrey, R.; Shewry, P.R.; Mills, E.N.C. The purification and characterization of allergenic hazelnut seed proteins. Mol. Nutr. Food Res. 2008, 52(2), 251-261.
24. Mills, E.N.C.; Marigheto, N.A.; Wellner, N.; Fairhurst, S.A.; Jenkins, J.A.; Mann, R.; Belton, P.S. Thermally induced structural changes in glycinin, the 11S globulin of soya bean (Glycine max)- an in situ spectroscopic study. Biochim. Biophys. Acta 2003, 1648(1-2), 105-114.
25. Zeller, H.; Novak, P.; Landgraf, R. Blood glucose measurement by infrared spectroscopy. Int. J. Artif. Organs 1989, 12(2), 129-135.
26. Marbach, R.; Koschinsky, T.; Gries, F.A.; Heise, H.M. Noninva-sive blood glucose assay by near-infrared diffuse reflectance spec-troscopy of the human inner lip. App. Spectrosc. 1993, 47(7), 875-881.
27. Heise, H.M.; Marbach, R.; Koschinsky, T.; Gries, F.A. Artif. Organs 1994, 18(6), 439.
28. De Blasi, R. A.; Ferrari, M.; Natali, A.; Conti, G.; Mega, A.; Gas-paretto, A. Noninvasive measurment of forearm blood flow and oxygen consumption by near-infrared spectroscopy. J. Appl. Physiol. 1994, 76, 1388-1393.
29. Müller, U.A.; Mertes, B.; Fischbacher, C.; Jageman, K.U.; Danzer, K. Non-invasive blood glucose monitoring by means of near infrared spectroscopy: methods for improving the reliability of the calibration models. Int. J. Artif. Organs 1997, 20(5), 285-290.
30. Fischbacher, C.; Jagemann, K.U.; Danzer, K.; Müller, U.A.; Papenkordt, L.; Schüler, J. Enhancing calibration modles for non-invasive near-infrared spectroscopical blood glucose determination. J. Anal. Chem. 1997, 359, 78-82.
31. Hovorka, R.; Kremen, J.; Blaha, J.; Matias, M.; Anderlova, K.; Bosanska, L.; Roubicek, T.; Wilinska, M.E.; Chassin, L.J.; Svac-ina, S.; Haluzik, M. Blood glucose control by a model predictive control algorithm with variable sampling rate versus a routine glucose management protocol in cardiac surgery patients: a randomized controlled trial. J. Clin. Endocrinol. Metabol. 2007, 92(8), 2960-2964.
32. Heise, H.M.; Bittner, A.; Marbach R. Near-infrared reflectance spectroscopy for noninvasive monitoring of metabolites. Clin. Chem. Lab. Med. 2000, 38(2), 137-145.
33. Marbach, R.; Heise, H.M. On the efficiency of algorithms for mul-tivariate linear calibration used in analytical spectroscopy. Trends Anal. Chem. 1992, 11(8), 270-275.
34. Marbach, R.; Heise, H.M. Calibration modeling by partial least-squares and principal component regression and its optimization using an improved leverage correction for prediction testing. Che-mom. Intell. Lab. Systems 1990, 9(1), 45-63.
35. Arnold, M.A.; Burmeister, J.J.; Small, G.W. Phantom glucose calibration models from simulated noninvasive human near-infrared spectra. Anal. Chem. 1998, 70(9), 1773-1781.
36. Arnold, M.A.; Small, G.W. Noninvasive glucose screening. Anal. Chem. 2005, 77, 5429-5439.
37. Du, Y. P.; Liang, Y.Z.; Kasemsumran, S.; Maruo, K.; Ozaki, Y. Removal of interference signals due to water from in vivo near-infrared (NIR) spectra of blood glucose by region orthogonal signal correction (ROSC). Anal. Sci. 2004, 20, 1339-1345.
38. Wold, S.; Antti, H.; Lindgren, F.; Öhman, J. Orhtogonal signal correction of near-infrared spectra. Chemom. Intell. Lab. Syst. 1998, 44, 175-185.
39. Wise, B.M.; Gallagher, N.B. http.//www.eigenvector.com/MATLAB/OSC.html.
40. Fearn, T. On orthogonal signal correction. Chemom. Intell. Lab. Syst. 2000, 50(1), 47-52.
41. Sjoblom, J.; Svensson, O.; Josefson, M.; Kullberg, H.; Wold, S. An evaluation of orthogonal signal correction applied to calibration transfer of near infrared spectra. Chemom. Intell. Lab. Syst. 1998, 44(1-2), 229-244.
42. Lehr, H. P.; Wickramasinghe, Y. New prototype NIRS to investigate multi-regional cerebral blood and tissue oxygenation and haemodynamics. Med. Biol. Eng. Comput. 2000, 38, 281-286.
43. Mosher, W.D. Fecundity and infertility in the United States. Am. J. Public Health 1988, 78(2), 181-183.
44. Mosher, W.D.; Pratt, W.F. Fecundity and infertility in the United States: incidence and trends. Fertil. Steril. 1991, 56(2), 192-193.
45. Wright, V.C.; Chang, J.; Jeng, G.; Macaluso, M. Assisted Reproductive Technology Surveillance --- United States, 2003. Surveil. Summ. 2006, 55(4), 1-22.
46. Wright, V.C.; Schieve, L.A.; Reynolds, M.A.; Jeng, G. Assisted reproductive technology surveillance --- united states, 2002. Surveil. Summ. 2005, 54(2), 1-24.
47. Andersen, A.N.; Gianaroli, L.; Nygren, K.G. Assisted reproductive technology in Europe, 2000. Results generated from European registers by ESHRE. Hum. Reprod. 2004, 19(3), 490-503.
48. Andersen, A.N.; Gianaroli, L.; Felberbaum, R.; de Mouzon, J.; Nygren, K.G. Hum. Reprod. 2005, 20(5), 1158.
49. Bromer, J.G.; Sakkas, D.; Seli, E. Metabolomic profiling of embryo culture media to predict IVF outcome. Expert Rev. Obstetrics Gynecol. 2008, 5(4), 441-447.
50. Nagy, Z.P.; Sakkas, D.; Behr B. Non-invasive assessment of embryo viability by metabolomic profiling to culture media (me-tabolomics). Reprod. BioMed. Online 2008, 17(4), 502-507.
51. Vergouw, C.G.; Botros, L.L.; Roos, P.; Lens, J.W.; Schats, R.; Hompes, P.G.A.; Burns, D.H.; Lambalk, C.B. Metabolomic profiling by near-infrared spectroscopy as a tool to assess embryo viability: a novel, non-invasive method for embryo selection. Hum. Reprod. 2008, 23(7), 1499-1504.
52. Handyside, A.H.; Pattinson, J.K.; Penketh, R.J.A.; Delhanty, J.D.A.; Winston, R.M.L.; Tuddenham, E.G.D. Biopsy of human preimplantation embryos and sexing by DNA amplification. Lancet 1989, 333(8634), 347-349.
53. McArthur, S.J,. Leigh, D.; Marshall, J.T.; de Boer, K.A.; Jansen, R.P.S. Pregnancies and live births after trophectoderm biopsy and preimplantation genetic testing of human blastocysts. Fertil. Steril. 2005, 84(6), 1628.
54. Liston, R.; Crane, J.; Hamilton, E.; Hughes, O.; Kuling, S.; MacKinnon, C.; McNamara, H.; Milne, K.; Richardson, B.; Tre-panie, M.J. Fetal health surveillance in labor. J. Obstet. Gynaecol. Can. 2002, 24(3), 250-276.
55. Mozurkewich, E.L.; Wolf, F. Near-infrared spectroscopy for fetal assessment during labor. Cochrane Database Syst. Rev. 2000, 3, CD002254.
56. Wyatt, J.S.; Edwards, A.D.; Azzopardi, D.; Reynolds, E.O.R. Magnetic Resonance and near infrared spectroscopy for investigation of perinatal hypoxic-ischiamic brain injury. Arch. Dis. Child. 1989, 64, 953-963.
57. Nicklin, S.; Hassan, I.; Wickramasinghe, Y.; Spencer, S. Arch. Dis. Child. Fetal Neonatal Ed. 2003, 88(4), F263.
58. McClaine, R.J.; Uemura, K.; de la Fuente, S.G.; Manson, R.J.; Booth, J.V.; White, W.D.; Campbell, K.A.; McClaine, D.J.; Benni, P.B.; Eubanks, S.; Reynolds, J.D. General anesthesia improves fetal cerebral oxygenation without evidence of subsequent neuronal injury. J. Cerebr. Blood Flow Metab. 2005, 25, 10601069.
59. O'Brien, P.M.; Doyle, P.M.; Rolfe, P. Near infrared spectroscopy in fetal monitoring. Br. J. Hosp. Med. 1993, 49(7), 483-487.
60. Rolfe, P.; Wickramasinghe, Y.A.; Thorniley, M.S.; Faris, F.; Houston, R.; Kai, Z.; Yamakoshi, K.; O'Brien, S.; Doyle, M.; Palmer, K. Fetal and neonatal cerebral oxygen monitoring with NIRS: theory and practice. Early Hum. Dev. 1992, 29(1-3), 269-273.
61. Faris, F.; Rolfe, P.; Thorniley, M.; Wickramasinghe, Y.; Houston, R.; Doyle, M.; O'Brien, S. Non-invasive optical monitoring of cerebral blood oxygenation in the foetus and newborn: preliminary investigation. J. Biomed. Eng. 1992, 74(4), 303-306.
62. D'Antona, D.; Aldrich, C.J.; O'Brien, P.; Lawrence, S.; Delpy, D.T.; Wyatt, J.S. Recent advances in fetal near infrared spectros-copy. J. Biomed. Opt. 1997, 2(1), 15-21.
63. Watkin, S.L.; Spencer, S.A.; Dimmock, P. W.; Wickramasinghe, Y.A.; Rolfe, P. A comparison of pulse oximetry and near infrared spectroscopy (NIRS) in the detection of hypoxaemia occurring with pauses in nasal airflow in neonates. J. Clin. Monit. 1999, 75, 441-447.
64. Strangman, G.; Boas, D.A.; Sutton, J. P. Non-invasive neuroimag-ing using near-infrared light. Biol. Psychiat. 2002, 52, 679-693.
65. Taillefer, M.C.; Denault, A.Y. Cerebral near-infrared spectroscopy in adult heart surgery: systematic review of its clinical efficacy. Can. J. Anesth. 2005, 52(1), 79-87.
66. Gough, K.; Rak, M.; Bookatz, A.; Del Bigio, M.; Mai, S.; Westa-way, D. Choices for tissue visualization with IR microspectro-scopy. Vib. Spectrosc. 2005, 38(1-2), 133-141.
67. Skoch, J.; Dunn, A.; Hyman, BT.; Bacskai, BJ. Development of an opticla approach for noninvasive imaging of Alzheimer's disease pathology. J. Biomed. Opt. 2005, 70(1), 11007/1-011007/7.
68. Hillman, E.M.C. Optical brain imaging in vivo: techniques and applications from animal to man. J. Biomed. Opt. 2007, 12(5), 051402.
69. Arnold, S.E.; Hyman, B.T.; Flory, J.; Damasio, A.R.; van Hoesen, G.W. The topographical and neuroanatomical distribution of neu-rofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex 1991, 1, 103-116.
70. Bierer, L.M.; Hof, P.R.; Purohit, D.P.; Carlin, L.; Schmeidler, J.; Davis, K.L.; Perl, D.P. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch. Neurol. 1995, 52, 81-88.
71. Galimberti, D.; Scarpini, E. New perspectives for the treatment of Alzheimer's disease. Open Geriatric Med. J. 2008, 7, 33-42.
72. Raygani, A.V.; Rahimi, Z.; Kharazi, H.; Tavilani, H.; Pourmo-tabbed, T. Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease. Neurosci. Lett. 2006, 408(1), 68-72.
73. Aleong, R.; Blain, J.F.; Poirier, J. Pro-inflammatory cytokines modulate glial apolipoprotein E secretion. Curr. Alzheimer Res. 2008, 5(1), 33-37.
74. Evans, K.C.; Berger, E. P.; Cho, C.G.; Weisgraber, K.H.; Lansbury, P. T. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc. Natl. Acad. Sci. 1995, 92, 763-767.
75. Hintersteiner, M.; Enz, A.; Frey, P.; Jaton, A.L.; Kinzy, W.; Kneuer, R.; Neumann, U.; Rudin, M.; Staufenbiel, M.; Stoeckli, M.; Wiederhold, K.H.; Gremlich, H.U. In vivo detection of amy-loid-p deposits by near-infrared imaging using an oxazine-derivate probe. Nat. Biotechnol. 2005, 23(5), 577-583.
76. Griebe, M.; Daffertshofer, M.; Stroick, M.; Syren, M.; Ahmad-Nejad, P.; Neumaier, M.; Backhaus, J.; Hennerici, M.G.; Fatar M. Infrared spectroscopy: a new diagnostic tool in Alzheimer disease. Neurosci. Lett. 2007, 420(1), 29-33.
77. Ray, S.; Britschgi, M.; Herbert, C.; Takeda-Uchimura, Y.; Boxer, A.; Blennow, K.; Friedman, L.F.; Galasko, D.R.; Jutel, M., Kary-das, A.; Kaye, J.A.; Leszek, J.; Miller, B.L.; Minthon, L.; Quinn, J.F.; Rabinovici, G.D.; Robinson, W.H.; Sabbagh, M.N.; So, Y.T.; Sparks, D.L.; Tabaton, M.; Tinklenberg, J.; Yesavage, J.A.; Tibshi-rani, R.; Wyss-Coray, T. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med. 2007, 73, 1359-1362.
78. Irizarry, M.C. Biomarkers of Alzheimer disease in plasma. Neu-roRx. 2004, 7(2), 226-234.
79. Peuchant, E.; Richard-Harston, S.; Bourdel-Marchasson, I.; Dar-tigues, J.F.; Letenneur, L.; Barberger-Gateau, P.; Arnaud-Dabernat, S.; Daniel, J.Y. Infrared spectroscopy: a reagent-free method to distinguish Alzheimer's disease patients from normal-aging subjects. Trans. Res., 2008, 752(3), 103-112.
80. Zhang, L.; Henson, M.J.; Sekulic, S.S. Multivariate data analysis for Raman imaging of a model pharmaceutical tablet. Anal. Chim. Acta 2005, 545(2), 262-278.
81. Shah, R.B.; Tawakkul, M.A.; Khan, M.A. Process analytical technology: Chemometric analysis of Raman and near infra-red spec-troscopic data for predicting physical properties of extended release matrix tablets. J. Pharm. Sci. 2007, 96(5), 1356-1365.
82. Furukawa, T.; Sato, H.; Shinizawa, H.; Noda, I.; Ochiai, S. Evaluation of homogeneity of binary blends of poly(3-hydroxybutyrate) and poly(L-lactic acid) studied by near infrared chemical imaging (NIRCI). Anal. Sci. 2007, 23(7), 871-876.
83. Dolbnev, D.V.; Dorofeev, V.L.; Arzamastsev, A.P.; Azimova, I.D.; Vakhtel, A.V.; Stepanova, E.V. Use of near-infrared spectropho-tometry (NIR) for identification of pharmaceutical drugs. Meditsin-skoi i Farmatsevticheskoi Khimii 2008, 6, 27-30.
84. Ulmschneider, M.; Wunenburger, A.; Penigault, E. Using near-infrared spectroscopy fort he noninvasive identification of five pharmaceutical active substances in sealed vials. Analysis 1999, 27(10), 854-856.
85. Elizarova, T.E.; Shtyleva, S.V.; Pleteneva, T.V. Using near-infrared spectrophotometry fort he identification of pharmaceuticals and drugs. Pharm. Chem. J. 2008, 42(7), 432-434.
86. Liu, F.; Zhao, W.; Liu, G.; Tang, Z.; Dou, Y.; Ren, Y. Nondestructive quality control of rutin pharmaceuticals by near infrared reflectance spectroscopy and artificial neural network. Huaxue Fenxi. Jil-iang 2003, 72(3), 11-13.
87. Alvarenga, L.; Ferreira, D.; Altekruse, D.; Menezes, J.C.; Lochmann, D. Tablet identification using near-infrared spectros-copy (NIRS) for pharmaceutical quality control. J. Pharm. Biomed. 2008, 48(1), 62-69.
88. Axon, T.G.; Brown, R.; Hammond, S.V.; Maris, S.J.; Ting, F. Focusing near infrared spectroscopy on the business objectives of 2966 modern pharmaceutical production. J. Near Infrared Spec. 1998, 6(1-4), A13-A19.
89. Ravn, C.; Skibstedb, E.; Bro, R. Near-infrared chemical imaging (NIR-CI) on pharmaceutical solid dosage forms - comparing common calibration approaches. J. Pharm. Biomed. 2008, 48(3), 554-561.
90. Storme-Parisa, I.; Clarot, I.; Esposito, S.; Chaumeil, J.C.; Nicolas, A.; Brion, F.; Rieutord, A.; Chaminade, P. Near InfraRed Spectroscopy homogeneity evaluation of complex powder blends in a small-scale pharmaceutical preformulation process, a real-life application. Eur. J. Pharm. Biopharm. 2008, 72(1), 189-198.
91. Yang, Z.; Leon, J.; Matrin, M.; Warder, J.W.; Zhang, R.; Liang, D.; Lu, W.; Tian, M.; Gelovani, J.G.; Qiao, A.; Li, C. Pharmacokinetics and biodistribution of near-infrared fluorescence polymeric nanoparticles. Nanotechnology 2009, 20(16), 165101.